DRL_RI

rituximab biosimilar · Dr. Reddy's Laboratories Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DRL_RI, covering 2024-01-22 to 2024-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma [Phase 3]

See pricing